CAS No.:97322-87-7

TOXICITY DATA with REFERENCE：

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
monkey	LD50	oral	> 2gm/kg (2000mg/kg)		Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 38, Pg. 1121, 1996.
mouse	LD	oral	> 300mg/kg (300mg/kg)		European Patent Application. Vol. #439321,
mouse	LD50	intraperitoneal	> 5gm/kg (5000mg/kg)		Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 26, Pg. 953, 1995.
mouse	LD50	intravenous	42mg/kg (42mg/kg)		Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 9, Pg. 759, 1967.
rat	LD50	intraperitoneal	> 4gm/kg (4000mg/kg)		Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 26, Pg. 953, 1995.
rat	LD50	oral	> 5gm/kg (5000mg/kg)		Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 26, Pg. 953, 1995.
women	TDLo	oral	840mg/kg/15W- (840mg/kg)	BRAIN AND COVERINGS: ENCEPHALITIS LIVER: "HEPATITIS (HEPATOCELLULAR NECROSIS), DIFFUSE" LIVER: "JAUNDICE, OTHER OR UNCLASSIFIED"	Annals of Internal Medicine. Vol. 129, Pg. 98, 1998.

Consensus Reports：

 

SAFETY PROFILE：

Safety Information of Troglitazone (CAS NO.97322-87-7):
Safety Statements: 22-24/25
22:  Do not breathe dust 
24:  Avoid contact with skin 
25:  Avoid contact with eyes 

Standards and Recommendations：

 

Analytical Methods：